Cryogenic logistics company Cryoport, Inc. has obtained another contract to support life sciences and cancer treatment technologies with its cryogenics management platform.
The California-based company has announced it will support biopharmaceutical outfit Gradalis, Inc.’s clinical trials to evaluate its investigational cellular immunotherapy for use in cancer treatments with its cryogenic solutions.
Cryoport’s global distribution network will provide the required cryogenic logistics support for multiple participating clinical sites located throughout the US. It will also extend access to patients currently enrolled in the trials.
... to continue reading you must be subscribed
